Evan Lippman
Corporate Officer/Principal chez ALNYLAM PHARMACEUTICALS, INC.
Postes actifs de Evan Lippman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21/09/2022 | - |
Historique de carrière de Evan Lippman
Anciens postes connus de Evan Lippman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AILERON THERAPEUTICS, INC. | Directeur Financier/CFO | 08/01/2015 | 31/12/2016 |
Intima Bioscience, Inc.
 Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Directeur des opérations | - | - |
| President | - | - | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 14/06/2012 | - |
Formation de Evan Lippman
| Bucknell University | Undergraduate Degree |
| Georgia State University | Undergraduate Degree |
| Cornell University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 2 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Health Technology |
- Bourse
- Insiders
- Evan Lippman
- Expérience
